Synthetic RNAs designed to fight cancer
In search of better cancer treatments, Xiaowei Wang, PhD, and his colleagues at the School of Medicine have designed synthetic molecules that combine the advantages of two experimental RNA therapies.
University’s research key in new international guidelines for treatment of severe malnutrition
The World Health Organization has released new guidelines for the treatment of severe acute malnutrition, based in large part on research at the School of Medicine. Shown is the school’s Mark Manary, MD, whose research helped spur the changes.
Heads or tails? Random fluctuations in brain cell activity may determine toss-up decisions
Coffee or tea? One of founders of an emerging field that combines economics and brain science reports new insights into decisions in which two choices are equally appealing.
Holtzman, Bateman win Chancellor’s Innovation Award
David M. Holtzman, MD, and Randall J. Bateman, MD, have been chosen as co-recipients of the Chancellor’s Award for Innovation and Entrepreneurship at Washington University in St. Louis.
Lecture Dec. 10 to honor former residency grad
John Olson Jr., MD, PhD, a 1998 graduate of the Washington University General Surgery Residency Program, will give a lecture in honor of the late Keith D. Amos, MD, at 5 p.m. Tuesday, Dec. 10, in Connor Auditorium at the Farrell Learning and Teaching Center on the Medical Campus. Olson also will receive an alumni award named for Amos.
Older adults see better in the doctor’s office
Older adults who have good vision when tested at their eye doctors’ offices may not see as well at home. A new study from researchers at the School of Medicine suggests dim lighting may be the culprit.
Better predictor of breast cancer risk developed
Epidemiologists have designed a better method to quantify a woman’s risk of developing breast cancer, according to Graham Colditz, MD, DrPH, at Washington University School of Medicine in St. Louis. The model could help identify women at high risk of breast cancer who may benefit from prevention strategies that reduce the chances of developing the disease.
NIH to fund ‘omics’ research into lung disease
The School of Medicine has been awarded a career-development grant to support junior faculty members interested in using “omics” technologies to diagnose, treat and prevent lung diseases. The grant, funded by the National Institutes of Health, will help train young pulmonary scientists to apply new analytic omics tools to the study of lung diseases.
Medical school instructors, house staff lauded
To show appreciation for exemplary service in medical education, School of Medicine students recently presented faculty and house staff with the annual Distinguished Service Teaching Awards. Shown are Nigar Kirmani, MD, (right) and other awardees enjoying the ceremony.
Among prescription painkillers, drug abusers prefer oxycodone
A nationwide survey of opioid drug abusers in rehab indicates that because of the high it produces, the prescription painkiller oxycodone is the most popular drug of choice. Hydrocodone, also prescribed to treat pain, is next in line. In all, some 75 percent of those surveyed rated one of these drugs as their favorite.
View More Stories